miRNA – molecular biomarkers in non-alcoholic fatty liver disease: potential targets in nutritional interventions
-
Published:2023
Issue:3
Volume:3
Page:18
-
ISSN:2972-2519
-
Container-title:Dietetician.ro
-
language:en
-
Short-container-title:Dietetician.ro
Reference40 articles.
1. Trefts E, Gannon M, Wasserman DH. The liver. Curr Biol. 2017;27(21):R1147–R1151. .
2. Tamber SS, Bansal P, Sharma S, Singh RB, Sharma R. Biomarkers of liver diseases. Mol Biol Rep. 2023;50(9):7815-7823.
3. Benedict M, Zhang X. Non-alcoholic fatty liver disease: an expanded review. World J Hepatol. 2017;9:715–32.
4. Pan JJ, Fallon MB. Gender and racial differences in nonalcoholic fatty liver disease. World J Hepatol. 2014;6(5):274–283.
5. Ofosu A, Ramai D, Reddy M. Non-alcoholic fatty liver disease: controlling an emerging epidemic, challenges, and future directions. Ann Gastroenterol. 2018;31:288–95.